Eileen Francis

Eileen Francis

Senior Reporter

Washington, DC

Eileen tracks developments in OTC drug research, manufacturing, regulation, finance, M&A and marketing. She favors stories on e-commerce trends and the industry's drive toward Rx-to-OTC drug switches. Eileen also contributes coverage on the dietary supplement industry. She has a keen eye for pieces that delve into the rising self-care movement and how it is raising the innovation bar for marketers.

Latest from Eileen Francis

Rhode Delivers: E.l.f. Beauty Posts Blowout Fiscal Q3 and Raises Full-Year Outlook

Oakland, Calif.-based E.l.f. Beauty Inc.’s reported sales in the fiscal third quarter soared 38% to $489.5m and its net income reached $39.4m, more than double what it achieved in the same period a year ago.

Estée Lauder Marks One Year of ‘Beauty Reimagined’ With Expanded Distribution, Innovation

The Estee Lauder Companies' ‘Beauty Reimagined’ initiative is paying off a year after launch, with expanded distribution of brands and ‘breakthrough’ innovations, the firm says during a Feb. 5 fiscal second quarter earnings presentation.

Estée Lauder Pays Fine For Violating Canadian Law Over Cosmetic PFAS

The Estee Lauder Companies, Inc. pleaded guilty to two counts of violating a Canadian Act that had required it to correct missteps related to selling products containing PFAS.

Super Bowl LX Ads: E.l.f. Kicks Off Telenovela; Dove Revisits Body Positivity; More

For Super Bowl LX on Feb. 8, e.l.f. Cosmetics will air a telenovela-inspired campaign with Academy Award-nominated actress Melissa McCarthy, as Dove features 30-second spot ‘The Game is Ours,’ to inspire body confidence in young girls. Separately, Manscaped launches first Super Bowl ad.

Revlon ColorSilk Claims Focus Of Henkel-Prompted NAD Assessment

New York-based Revlon was able to demonstrate substantiation for two claims for its namesake ColorSilk with bond Repair Complex hair color, while committing to modifying or discontinuing several other claims that the National Advertising Division concluded were not supported.

FDA Sheds Light On Broadened Record-Gathering Authority Under MoCRA

The US FDA published a Q&A draft guidance for cosmetic manufacturers on its expanded record-gathering authority under MoCRA, the types of documents that do not apply and the repercussions for stakeholders that do not comply with requests for data.